1. Home
  2. DRIO vs HYFT Comparison

DRIO vs HYFT Comparison

Compare DRIO & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

N/A

Current Price

$3.02

Market Cap

56.8M

Sector

Health Care

ML Signal

N/A

Logo MindWalk Holdings Corp.

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.10

Market Cap

56.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRIO
HYFT
Founded
2011
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.8M
56.5M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
DRIO
HYFT
Price
$3.02
$1.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
★ $12.33
$4.33
AVG Volume (30 Days)
54.6K
★ 304.3K
Earning Date
11-16-2026
12-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1559.02
N/A
EPS
★ 1.75
N/A
Revenue
★ $7,394,000.00
N/A
Revenue This Year
N/A
$12.86
Revenue Next Year
$38.77
$22.94
P/E Ratio
$1.72
★ N/A
Revenue Growth
★ 43.02
N/A
52 Week Low
$3.00
$0.99
52 Week High
$14.77
$3.00

Technical Indicators

Market Signals
Indicator
DRIO
HYFT
Relative Strength Index (RSI) 25.14 34.43
Support Level $3.01 $1.03
Resistance Level $8.10 $1.50
Average True Range (ATR) 0.57 0.10
MACD -0.08 -0.02
Stochastic Oscillator 4.90 4.93

Price Performance

Historical Comparison
DRIO
HYFT

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: